Pavlova, I., 2015. Effect of probiotics on doxycycline disposition in gastro-intestinal tract of poultry. Bulg. J. Vet. Med., 18, No 3,[248][249][250][251][252][253][254][255][256][257] Poultry feed is often supplemented with probiotics in order to improve disease resistance and growth performance and to decrease undesirable effects of antibacterial therapy. Therefore this study was designed to evaluate the effect of probiotics such as Lactobacillus brevis, L. plantarum and L. bulgaricus on pharmacokinetics of doxycycline in healthy DUC broiler chickens. The treatment with doxycycline at a dose of 10 mg/kg body weight started on the 15 th day after hatching for 5 days via drinking water. The probiotics treated group received Lactobacillus strains for 15 days, 5 days after hatching. Treatment with probiotics did not lead to statistically significant differences in serum concentrations of doxycycline between both groups of chickens. The value of C max was significantly higher in the liver of doxycycline + probiotics treated chickens (0.23±0.1 µg/g) than in doxycycline-treated group (0.19±0.17 µg/g). The same tendency was observed in the jejunum of both groups of animals suggesting favourable results in the cure of bacterial diseases of the gastrointestinal tract of poultry.The selected dose was appropriate for treatment of infections caused by pathogens with MIC < 0.25 µg/mL irrespective of antibiotic administration alone or in combination with probiotics. The simultaneous treatment of chickens with probiotics and doxycycline did not entail changes in the dose regime of the antibiotic.
INTRODUCTION
The increasing antimicrobial resistance in livestock and poultry becomes a serious problem worldwide. Therefore alternatives to improve disease resistance and growth performance in high intensity food animal production are required. Nowadays, the combination of solutions such as strict disinfection in and around the poultry house, food and water quality improvement and vaccination are employed to achieve high performance in poultry industry (Doyle & Erickson, 2006) . Nutritional strategies and some feed additives such as organic acids, acidifiers, probiotics, oligosaccharides, herbs and essential oils were used as alternatives to antibio-tics to ensure gut health and enteric disease resistance (Denli et al., 2003; Ferket, 2004) . Probiotics are widely applied as feed additives in poultry farming due to proven health benefit to the host. Probiotics as lactobacilli, positively modulate the host immunity (Huang et al., 2004; Apata, 2008) . Their beneficial effects on gastrointestinal disturbances are attributed to the production of antimicrobial substances such as lactic acid and bacteriocins, competitive adherence of probiotic strains to the intestinal mucosa, which prevents colonisation by pathogens, strengthening of the gut epithelial barrier and modification of the gut microbiota. The efficacy of probiotics depends on factors including microbial species composition (e.g., single or multiple strains) and viability, application method and frequency, administration level, diet composition, bird age and environmental stress factors (Mountzouris et al., 2010) . Many probiotic strains such as Lactobacillus spp., Streptococcus spp., Bifidobacterium and Bacillus spp. used in poultry have resulted in higher body weight gain, better feed conversion and reduced mortality (Edens, 2003; Griggs & Jacobs, 2005; Kabir, 2009; Santini et al., 2010) . The superior effect of fermented probiotics on growth performance of broiler chickens was proven and according to the results, probiotics were recommended for routine use in the poultry feed (Ashayerizadeh et al., 2014) .
The gut microbiota is now recognised to exert an important influence on the absorption and pharmacokinetics of many compounds. Probiotics, through its modulation, can play a role in changes of drug pharmacokinetics (Stojancevic et al., 2013) . Despite their advantages, probiotics are not a universal alternative to antibiotics. In some bacterial diseases they are used simultaneously with drugs, including antibiotics. Tetracyclines are widely used in poultry as prophylactic and therapeutic agents. Doxycycline is a semi-synthetic, bacteriostatic and a broad spectrum antibiotic with pharmacokinetic properties superior to those of older tetracyclines: higher lipid solubility, complete absorption, better tissue distribution, longer elimination half-life and lower affinity for calcium. Many of these pharmacokinetic characteristics have been studied in detail, mainly in humans but also in animals (Cars & Ryan, 1988) . A few pharmacokinetic studies have been done in chickens (Anadon et al., 1994) . Animal studies showed that administration of chlortetracycline and probiotics in the feed improved pig performance but did not show any pharmacokinetic interaction with probiotics (Choi et al., 2011) . Mechanisms of action of probiotics, as well as interactions with antibiotics, the host and the gastro-intestinal microbiota are not completely understood (Modesto et al., 2009) . Previous studies elucidated drug-drug pharmacokinetic interactions of flunixin meglumine (Yang et al., 2012) , diclazuril, halofuginone (El-Gendi et al., 2010) , mycotoxins (Atef et al., 2002) and doxycycline in broilers but there is lack of information about the effect of probiotics on the disposition of this antibacterial agent.
Therefore, the aim of the present study was to investigate the pharmacokinetics of doxycycline, administered alone or in combination with probiotics in DUC broiler chickens.
MATERIALS AND METHODS

Drug
Doxycycline hyclate (Doxy-200 ws, Interchemie, Venray, Holland) was used for treatment.
Doxycycline hyclate ≥98% (TLC) Lot# BCBF9827V (Sigma) and Oxytetracycline hydrochloride ≥95% (HPLC grade) Lot# BCBG9599V (Sigma) were used as internal standards during the HPLC analysis.
Probiotics
Lactobacillus brevis, L. plantarum and L. bulgaricus (a laboratory collection of The Stephan Angeloff Institute of Microbiology, BAS, Bulgaria) were pre-selected as candidate-probiotic strains (Danova et al., 2012) . They were cultured overnight in skimmed milk (Humana, Germany), lyophilised and stored at -20 o C until the experiments. The lyophilised samples of L. brevis (1.6×10
6 CFU/mg lyophilised product), L. plantarum (1.06×10 6 CFU/mg) and L. bulgaricus (0.25×10 3 CFU/mg product) were used. The strains were resistant to doxycycline.
Animals and husbandry
One hundred one-day-old DUC chickens were taken from a commercial hatchery. The birds were placed, according to the species requirements in the animal house of the Department of Pharmacology. Clinical signs of disease were not observed during the trial. In the animal house, a room temperature 26-28 °C and 24 hours lighting were maintained. Water and food (broiler starter withoutany drugs) were supplied ad libitum. The experimental procedure was approved by the Ethical Committee at Trakia University, Stara Zagora (Reference No 65/18.10.2013).
Experimental design
The chickens were allocated in two groups: Group I (n=48) received doxycycline and Group II (n=48) was treated with probiotics and doxycycline. The other 4 chickens were untreated and were used for obtaining control serum and tissue samples. Probiotics were administered on the 5 th day after hatching for 15 days via feed at a dose rate of 1 g of each probiotic strain/kg feed. They were daily added to the feed which was stored at -20 °C until delivery to the chickens. The treatment with doxycycline started 15 days after hatching and lasted for 5 consecutive days. The antibacterial drug was administered via drinking water at a dose of 10 mg/kg body weight. Each day, the solutions in drinking water were freshly prepared between 7.30 and 8 h in the morning and between 16 and 17 h in the afternoon. Blood samples (each of 0.7 mL) were taken 2, 3, 4, 6, 9, 12, 15, 24, 122, 124, 126, 129 and 144 hours after the start of drug administration from the brachial vein of chickens from both groups. They were collected from six animals from each group and at each time interval so that no more than 0.7 mL blood was taken per chicken during the sampling. Serum was separated after centrifugation of blood samples at 1800×g for 15 min and was stored at -70 °C until analysis. Tissue samples (from liver, duodenum and jejunum) were collected on hours 122, 124, 126, 129 and 144 after the beginning of the treatment. Six animals from each group were euthanised at each time interval. Tissue samples were stored at -70 °C.
Drug analysis
Doxycycline concentrations were analysed by high-performance liquid chromatograph (HPLC) coupled with PDA detector (Baert et al., 2000) . Shortly, 15 μL of the internal standard (11 μg/mL oxytertacycline) and 19.5 μL trifluoroacetic acid were added to 150 μL of serum samples. After vortexing, the samples were centrifuged for 10 min at 10800×g at 22 °С.
The supernatants were transfered to HPLC vials and 20 µL were injected into the HPLC system (Thermo Fisher Scientific Inc., USA) (Laczay et al., 2001 ). The standard solutions of doxycycline were prepared in serum from untreated animals at concentrations of 20, 10, 5, 2.5, 1, 0.5, 0.25 and 0.125 μg/mL. They were processed according to the described procedure.
The tissue samples (1 g) were homogenised in 0.5 mL oxalate buffer and 100 μL inner standard. After vortexing, 5 mL 0.4M oxalate buffer were added to each sample, left to stand 15 min and centrifuged for 15 min at 4000×g. The supernatants were decanted into clean tubes and the residues were reextracted twice. After filtration, the supernatants were applied to SPE cartriges (BAKERBOND SPE Column C18 200 mg/3 mL; Lot No. 1308100010) preconditioned with 2 mL methanol and 2 mL water. Elution was performed with a mixture of methanol/acetonitrile/0.01M oxalic acid according to Nikolaidou et al. (2008) . The eluents were evaporated to dryness at 40 °С and the dry residues were reconstituted in 100 μL of methanol; then 20 μL were injected into the HPLC system (Nikolaidou et al., 2008) . Standard curves were prepared with tissue samples from untreated animals and solutions of doxycycline with concentration 20, 10, 5, 2.5 and 1 μg/mL.
Pharmacokinetic analysis
Pharmacokinetic parameters were calculated with Phoenix 6.0 software (Pharsight Corporation, Mountain View, CA, USA) using non-compartmental analysis and one-compartmental analysis with absorption after naive pooling of serum drug concentrations. Pharmacokinetic parameters with non-compartmental analysis were estimated with sparse sampling option. Naive pooling was done by using all individual data. Pharmacokinetic parameters for serum were first calculated on the basis of mean serum concentrations for each sampling time. In addition, the subject information was used to calculate standard errors that account for any correlations in the data, resulting from repeated sampling of individual animals. Standard error of the mean C max was calculated as the sample standard deviation of the yvalues at time T max divided by the square root of the number of observations at T max , or equivalently, the sample standard error of the y-values at T max . AUC was calculated by the linear trapezoidal rule. Noncompartmental model was applied for analysis of tissue concentrations. The major pharmacokinetic/pharmacodynamic (PK/PD) index determining doxycycline's in vivo efficacy is the time of serum concentration exceeding the MIC (minimal inhibitory concentration) (T > MIC) (Toutain et al., 2002) . It was calculated on the basis of MIC value of doxycycline in broth -0.25 µg/mL and serum -1 µg/mL for the pathogenic strain E. coli O78/H12. MIC values were determined according to Clinical and Laboratory Standards Institute, (2008) .
Statistical analysis
Statistical analysis was performed with Mann-Whitney test (Prism 4.0 software). Level of significance was set at P < 0.05.
RESULTS
Pharmacokinetic parameters were calculated with one-compartmental analysis and non-compartmental analysis of sparse data in order to characterise absorption and elimination phases. The differences in serum levels between both groups of chickens were not statistically significant (Table 1, Fig. 1 ). The non-compartmental analysis of sparse data showed statistically insignificant differences in the values of T max , C max , C min and C avg with higher fluctuations in the doxycycline treated group in comparison to doxycycline+ probiotics treated chickens. The accumulation index was 1.08 for the animals that received doxycycline and probiotics and 1.28 for the group treated with doxycycline only. These values showed that there were no indices for accumulation of the drug in this animal species.
The value of C max was significantly higher in the liver of doxycycline+probio-tics treated chickens (0.23±0.1 µg/g at 122 h and 0.218±0.06 µg/g at 124 h) than in the doxycycline-treated group (0.19±0.17 µg/g at 122 h; not determined at 124 h). The same tendency was observed in the jejunum of both groups of animals -0.05±0.01 µg/g and 0.03± 0.0 µg/g, respectively. Similar values were obtained in the duodenum (0.20±0.05 µg/g and 0.22±0.04 µg/g, respectively).
Our results showed that pharmacokinetic-pharmacodynamic indices in both groups were similar. Assuming a MIC value of 0.25 μg/mL, Т > MIC was over 80% for the whole time of the treatment. The antibiotic concentrations during the 5-day treatment were higher than serum MIC value (Fig. 1) .
DISCUSSION
Antimicrobial therapy is an important tool in reducing both the incidence of infectious diseases and mortality in poultry husbandry. Although few pharmacokinetic studies have been done in chickens after prolonged administration via drinking water, doxycycline is often used to treat avian infectious diseases such as colibacillosis, pasteurellosis, mycoplasmosis and chlamydiosis (Butaye et al., 1997; K ab -absorption rate constant; K el -elimination rate constant; AUC0→∞ -area under the concentration-time curves; T 1/2β -elimination half-life; T 1/2abs -absorption half-life; C max -maximum serum levels; T max -time of C max ; C min -minimum serum levels; C avg -average serum levels. et al., 1998; Burch & Valks, 2002) . The use of doxycycline for the treatment of experimentally induced colibacillosis in broilers through the drinking water was evaluated as effective (Akbar et al., 2009 ). Doxycycline at a dose of 10 mg/kg, administered for five days resulted in a complete clinical and bacteriological healing of the broilers with colisepticemia (Cristina et al., 2010) . In poultry farming, antibiotics may be administered through feed or drinking water to whole flocks rather than to individual animals. This fact may contribute for increasing the emergence of resistant bacteria due to unequal administration of the drug in the flock which could be a risk for public health (Miranda et al., 2008) . Hence, it is important to optimise dosing regimen of antibiotics when they are used in combination with other drugs or additives in order to maintain efficacy and reduce selection of resistance. Therefore in our study we investigated the effect of probiotics such as Lactobacillus spp. on pharmacokinetics of doxycycline. Despite probiotics are routinely used in poultry husbandry, the effect of their administration on doxycycline disposition pharmacokinetics has not been described.
The results from the current study showed that pharmacokinetics of doxycycline in three weeks old DUC broiler chickens was similar to published data (Espigol et al., 1997) . The higher values of C max (5.36±0.26 μg/mL) and T max (3.60±0.26 μg/mL) were obtained by Hantash et al. (2008) after administration of a single oral dose. The differences can be explained by the route of drug administration, which in our experiment resulted in slower rate and lesser extent of absorption Previous studies with probiotic Lactobacillus strains, administered in the feed of broilers indicated that morphology of duodenum was significantly changed by increasing the length of villi and crypt depth (Sharifi et al., 2012) . It is well known that lactobacilli have low activities of metabolizing enzymes, produce organic acids with a resulting decrease in pH of the intestines, increase the expression of tight junction proteins and as a result, strengthen the gut epithelial barrier (Stojancevic et al., 2013) . However, the possible effect of these changes on doxycycline absorption has not been studied. In our experiments, doxycycline disposition was not significantly altered by the probiotics treatment. Significantly higher concentrations of doxycycline in the liver and intestinal tissues in probiotic-treated group in comparison to the chickens, treated with the antibacterial drug only, indicated that probiotics did not modulate the disposition of doxycycline in the intestines and increased antibacterial concentrations in the liver -a prerequisite for successful treatment of gastro-intestinal infections in broilers. Doxycycline possess a bacteriostatic activity. Last decade the pharmacokinetic/ pharmacodynamic approach was used to predict clinical efficacy and to minimise the risk for selection of resistant bacteria (McKellar et al., 2004) . The measured serum concentrations of doxycycline in both groups of chickens were twice as high than MIC value (0.25 μg/mL) 2 h after the start of drug administration. They were still higher but close to MIC in broth 2 h after the end of the treatment. Pk/Pd analysis shows that the calculated indices exceeded the breakpoints values, ensured clinical cure and minimised the risk of resistance in our experimental conditions. Probiotics treatment did not change Pk/Pd indices indicating that adjustment of dosage after feed supplementation with Lactobacillus probiotic strains was not necessary.
In conclusion, probiotic treatment provoked no statistically significant differences in serum concentrations vs the doxycycline only treated group. The simultaneous treatment of chickens with probiotics and doxycycline did not require changes in the dose regimen. Significantly higher concentrations of doxycycline were detected in the liver of probiotic-treated animals. The same tendencies were found in the jejunum: the co-administration of probiotics and doxycycline resulted in higher concentrations of doxycycline, suggesting favourable results in the cure of bacterial diseases of poultry gastrointestinal tract. According to our experimental conditions no adjustment of dosage regimens of doxycycline, when combined with probiotics from the Lactobacillus spp. was necessary.
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